[1] |
Wagner WH.J Nucl Med. 1990;31:17A.
|
[2] |
Wagner WH.J Nucl Med. 1992;33:LON.
|
[3] |
Wagner WH.J Nucl Med. 1991;32:11N.
|
[4] |
Leonard BE et al. Neuropharmcology,1984;23:213.
|
[5] |
Comar D et al.Nature 1979;280:329.
|
[6] |
Comar D et al.Psychiatry Res,1979;1:23.
|
[7] |
Maziere B.Eur J Nucl Med. 1990;16:817.
|
[8] |
Friedman AM et al Int J Nucl Med Biol 1982;9:57.
|
[9] |
Wagner WH.et al Science,1983;221:1264.
|
[10] |
Laduron PM et al.Biochem Pharmcol,1984;33:833.
|
[11] |
Stoof JC.Life Sci,1984;35:2281.
|
[12] |
Wang DF et al:Science,1986;234:1558.
|
[13] |
Mertens J et al J Nucl Med,1989;30:926.
|
[14] |
Kung HF et al.J Nucl Med,1989;30:88.
|
[15] |
Loch C et al.Eur J Nucl Med,1989;15,413.
|
[16] |
Tatsch K et al J Nucl Med,1991;32:1014.
|
[17] |
Rutgers AW et al.J Ncuro Sci,1987;380:237.
|
[18] |
Lenders KL et al.Mov Disord 1986;1:69.
|
[19] |
Friedman AM et al.Eur J Pharmacol,1985;108:327.
|
[20] |
Dodds HN et al.J Pharmacol Exp Ther,1987;262:257.
|
[21] |
Holman BL et al.JAMA,1985;254:3063.
|
[22] |
Maziere C.Costa E GAMA and Benzadiazepin Receptors New York:Raven Press 1981:273.
|
[23] |
Schubiger PA et al Nucl Med Commu,1991;12-569.
|
[24] |
Leysen JE et al. Neuropharmacology,1984;23:1493.
|
[25] |
Jones AKP et al.J Neurosci Methods 1988;23:121.
|
[26] |
Nybak H et al.Prog Brain Rss 1989;79:313.
|